Literature DB >> 9405940

Chlamydia pneumoniae respiratory infections among patients infected with the human immunodeficiency virus.

U V Comandini1, P Maggi, P Santopadre, R Monno, G Angarano, V Vullo.   

Abstract

Thirteen cases of Chlamydia pneumoniae infection in patients seropositive for the human immunodeficiency virus (HIV) are described. The occurrence, the clinical spectrum, and the significance of the infection during HIV disease are compared with data reported in the literature. Chlamydia pneumoniae infection was established by a serologic micro-immunofluorescence test using standard diagnostic criteria. In four cases the results of serological tests were confirmed by direct immunofluorescence on respiratory specimens. Five patients developed focal pneumonia but recovered completely after specific antibiotic treatment. Three patients developed severe and diffuse interstitial pulmonary involvement, two of whom died of acute respiratory failure. Five patients developed upper respiratory tract infection. Using 39 pair-matched HIV-seropositive subjects as controls, the cases of infection were found to be significantly associated with a previously diagnosed pulmonary disease. Upon retrospective analysis of 319 consecutive cases of pneumonia among HIV-infected patients, Chlamydia pneumoniae was the sole agent detected in eight (2.5%) cases, and Chlamydia pneumoniae together with other infectious agents was detected in seven (2.2%) cases. Chlamydia pneumoniae is a possible cause of severe respiratory infection in Italian HIV-infected immunocompromised patients, and its presence must be suspected when patients do not respond to therapy with beta-lactam agents or to anti-Pneumocystis carinii treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405940     DOI: 10.1007/bf01709251

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  28 in total

Review 1.  Relevance of Chlamydia pneumoniae in community-acquired respiratory infections.

Authors:  A Torres; M el-Ebiary
Journal:  Eur Respir J       Date:  1993-01       Impact factor: 16.671

2.  Preliminary data on Chlamydia pneumoniae seroprevalence in HIV-1 infected children.

Authors:  A Plebani; M C Schoeller; F Blasi; R Cosentini
Journal:  Ann N Y Acad Sci       Date:  1993-10-29       Impact factor: 5.691

Review 3.  HIV-associated respiratory diseases.

Authors:  R Miller
Journal:  Lancet       Date:  1996-08-03       Impact factor: 79.321

Review 4.  Chlamydia pneumoniae (TWAR).

Authors:  C C Kuo; L A Jackson; L A Campbell; J T Grayston
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

5.  Community-acquired pneumonia: impact of immune status.

Authors:  L M Mundy; P G Auwaerter; D Oldach; M L Warner; A Burton; E Vance; C A Gaydos; J M Joseph; R Gopalan; R D Moore
Journal:  Am J Respir Crit Care Med       Date:  1995-10       Impact factor: 21.405

6.  Asymptomatic respiratory tract infection with Chlamydia pneumoniae TWAR.

Authors:  C L Hyman; M H Augenbraun; P M Roblin; J Schachter; M R Hammerschlag
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

7.  Chlamydia pneumoniae infection in acute exacerbations of COPD.

Authors:  F Blasi; D Legnani; V M Lombardo; G G Negretto; E Magliano; R Pozzoli; F Chiodo; A Fasoli; L Allegra
Journal:  Eur Respir J       Date:  1993-01       Impact factor: 16.671

8.  Spread of subclinical Chlamydia pneumoniae infection in a closed community.

Authors:  B P Berdal; O Scheel; A R Ogaard; T Hoel; T J Gutteberg; G Anestad
Journal:  Scand J Infect Dis       Date:  1992

9.  Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone.

Authors:  R Malinverni; C C Kuo; L A Campbell; J T Grayston
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

10.  Nonspecific interstitial pneumonitis without evidence of Pneumocystis carinii in asymptomatic patients infected with human immunodeficiency virus (HIV).

Authors:  F P Ognibene; H Masur; P Rogers; W D Travis; A F Suffredini; I Feuerstein; V J Gill; B F Baird; J A Carrasquillo; J E Parrillo
Journal:  Ann Intern Med       Date:  1988-12-01       Impact factor: 25.391

View more
  3 in total

1.  Transspecies transmission of the endogenous koala retrovirus.

Authors:  Uwe Fiebig; Manuel Garcia Hartmann; Norbert Bannert; Reinhard Kurth; Joachim Denner
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

2.  Infection with koala retrovirus subgroup B (KoRV-B), but not KoRV-A, is associated with chlamydial disease in free-ranging koalas (Phascolarctos cinereus).

Authors:  Courtney A Waugh; Jonathan Hanger; Joanne Loader; Andrew King; Matthew Hobbs; Rebecca Johnson; Peter Timms
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

Review 3.  Atypical bacterial pneumonia in the HIV-infected population.

Authors:  Breanne M Head; Adriana Trajtman; Zulma V Rueda; Lázaro Vélez; Yoav Keynan
Journal:  Pneumonia (Nathan)       Date:  2017-08-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.